These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17256723)

  • 21. Noninvasive assessment of liver disease severity with liver fat score and CK-18 in NAFLD: Prognostic value of liver fat equation goes beyond hepatic fat estimation.
    Musso G; Gambino R; Durazzo M; Cassader M
    Hepatology; 2010 Feb; 51(2):715-7. PubMed ID: 19821531
    [No Abstract]   [Full Text] [Related]  

  • 22. [Regression of fatty liver].
    Thaler H
    Dtsch Med Wochenschr; 1989 Aug; 114(31-32):1224. PubMed ID: 2666084
    [No Abstract]   [Full Text] [Related]  

  • 23. Non alcoholic steatohepatitis.
    Zantout H; Barada K
    J Med Liban; 2001; 49(2):90-3. PubMed ID: 11910973
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV; Hadziyannis E; Tsochatzis E; Chrysanthos N; Georgiou A; Kafiri G; Manolakopoulos S; Tiniakos DG; Giannousis I; Manesis EK; Archimandritis AJ
    Gut; 2008 Apr; 57(4):500-6. PubMed ID: 18025069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.
    Pagadala M; Zein CO; McCullough AJ
    Clin Liver Dis; 2009 Nov; 13(4):591-606. PubMed ID: 19818307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Letter: diagnostic accuracy of M30 levels for identifying patients with non-alcoholic steatohepatitis.
    Yilmaz Y
    Aliment Pharmacol Ther; 2013 Jan; 37(2):283. PubMed ID: 23252784
    [No Abstract]   [Full Text] [Related]  

  • 27. Letter: diagnostic accuracy of M30 levels for identifying patients with non-alcoholic steatohepatitis--authors' reply.
    Shen J; Wong VW
    Aliment Pharmacol Ther; 2013 Jan; 37(2):283-4. PubMed ID: 23252785
    [No Abstract]   [Full Text] [Related]  

  • 28. Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C.
    Yilmaz Y; Dolar E; Ulukaya E; Akgoz S; Keskin M; Kiyici M; Yerci O; Oral AY; Gul CB; Gurel S; Nak SG; Gulten M
    Med Sci Monit; 2009 Apr; 15(4):CR189-93. PubMed ID: 19333204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum levels of keratin-18 fragments [tissue polypeptide-specific antigen (TPS)] are correlated with hepatocyte apoptosis in alcoholic hepatitis.
    Gonzalez-Quintela A; Abdulkader I; Campos J; Fernandez-Hernandez L; Lojo S
    Dig Dis Sci; 2009 Mar; 54(3):648-53. PubMed ID: 18618253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease.
    Adams LA; Angulo P
    Clin Liver Dis; 2007 Feb; 11(1):25-35, viii. PubMed ID: 17544970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Commentary: assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers.
    Miller MH; Dillon JF
    Aliment Pharmacol Ther; 2013 Jan; 37(2):275. PubMed ID: 23252776
    [No Abstract]   [Full Text] [Related]  

  • 32. After goodbye? Dead hepatocytes as a biomarker for fibrosis and steatohepatitis.
    Choi S; Diehl AM
    Hepatology; 2012 Feb; 55(2):333-5. PubMed ID: 22183709
    [No Abstract]   [Full Text] [Related]  

  • 33. Commentary: assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers--authors' reply.
    Shen J; Wong VW
    Aliment Pharmacol Ther; 2013 Jan; 37(2):276. PubMed ID: 23252777
    [No Abstract]   [Full Text] [Related]  

  • 34. Sensitive non-invasive circulating markers in paediatric non-alcoholic fatty liver disease.
    Alisi A; Nobili V
    Pediatr Obes; 2012 Apr; 7(2):89-91. PubMed ID: 22434747
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis.
    Chen C; Schmilovitz-Weiss H; Liu XE; Pappo O; Halpern M; Sulkes J; Braun M; Cohen M; Barak N; Tur-Kaspa R; Vanhooren V; Van Vlierberghe H; Libert C; Contreras R; Ben-Ari Z
    J Proteome Res; 2009 Feb; 8(2):463-70. PubMed ID: 19140676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnosis of alcoholic hepatitis].
    Biermann J; Bode JC
    Dtsch Med Wochenschr; 1987 Feb; 112(9):347-9. PubMed ID: 3545752
    [No Abstract]   [Full Text] [Related]  

  • 37. Alcohol and the liver: 1. Acute alcoholic hepatitis.
    Mistilis SP; Barr GD
    Med J Aust; 1980 Aug; 2(4):182, 184-8. PubMed ID: 7432281
    [No Abstract]   [Full Text] [Related]  

  • 38. [Non-alcoholic steatohepatitis].
    Fehér J
    Orv Hetil; 2002 Aug; 143(32):1875-7. PubMed ID: 12221992
    [No Abstract]   [Full Text] [Related]  

  • 39. Marked elevation of serum mitochondrion-derived markers in mild models of non-alcoholic steatohepatitis in rats.
    Murayama H; Ikemoto M; Nagata A
    J Gastroenterol Hepatol; 2009 Feb; 24(2):270-7. PubMed ID: 18823438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FibroMAX: towards a new universal biomarker of liver disease?
    Morra R; Munteanu M; Imbert-Bismut F; Messous D; Ratziu V; Poynard T
    Expert Rev Mol Diagn; 2007 Sep; 7(5):481-90. PubMed ID: 17892356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.